• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS CORPORATION PRECISE PRO RX US CAROTID SYST; STENT, CAROTID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS CORPORATION PRECISE PRO RX US CAROTID SYST; STENT, CAROTID Back to Search Results
Model Number PC0840RXC
Device Problem Difficult or Delayed Positioning (1157)
Patient Problem Not Applicable (3189)
Event Date 05/29/2018
Event Type  malfunction  
Manufacturer Narrative
During a right internal carotid artery stenting procedure, the precise pro rx self-expanding stent delivery system (ses) could not cross the lesion in the heavily calcified right internal carotid artery (ica).No patient injury was reported.No information was reported regarding how the procedure was completed.The product was stored and handled according to the instructions for use (ifu).The product was inspected and prepped according to the ifu.There was nothing unusual noted about the stent delivery system prior to use.The device was prepped in the tray.When removed from the tray, the stent was not constrained within the outer member/sheath.The tuohy borst valve was closed prior to removing the device from the tray.A stopcock was connected to the y-connector of the tuohy borst valve.There was no difficulty encountered flushing the stopcock.There was no difficulty encountered flushing the stent delivery system (sds).The patient had right and left ica stenosis.The intended lesion was not located at the carotid bifurcation.The diameter of the unconstrained stent size was 1-2 mm larger than the vessel diameter.The stent delivery system did not pass through any acute bends.There was difficulty encountered while advancing/tracking the sds towards the lesion.There was unusual force used during the procedure.The lesion was pre-dilated prior to stent implantation.An unknown 4x40 balloon catheter was used to pre-dilate the lesion prior to stent implantation.Nominal pressure was used.The percent of stenosis after pre-dilation is 60%.The contrast was mixed with saline and the ratio of the contrast to fluid was 2:1.There was difficulty advancing the sds over the guidewire or embolic protection device.The difficulty occurred in the vessel.No additional information was reported.The device was not returned for analysis.A product history record (phr) review of lot 17724100 revealed no anomalies or non-conformances during the manufacturing and inspection processes that can be associated with the reported event.The phr review does not suggest that the event reported by the customer could be related to the manufacturing process.The reported ¿stent delivery system (sds)-ses failure to cross¿ and ¿stent delivery system (sds)-ses deployment difficulty - premature/prior to use¿ could not be confirmed.The device was not retuned for analysis and procedural films were not received.The exact cause could not be determined.Vessel characteristics, as well as procedural and handling factors may have contributed to the reported events.According to the instructions for use (ifu), ¿extract the stent delivery system from the tray.Examine the device for any damage.Evaluate the distal end of the catheter to ensure that the stent is contained within the outer sheath.Do not use if the stent is partially deployed.If a gap between the catheter tip and outer sheath tip exists, open the tuohy borst valve and gently pull the inner shaft in a proximal direction until the gap is closed.Lock the tuohy borst valve after the adjustment by rotating the proximal valve end in a clockwise direction.If resistance is met during delivery system introduction, the system should be withdrawn, and another system used.¿ the phr review does not suggest that the events experienced by the customer could be related to the manufacturing process.Therefore, no corrective or preventive actions will be taken at this time.
 
Event Description
As reported, the physician attempted to stent a heavily calcified right internal carotid artery (ica) but the precise pro rx self-expanding stent delivery system (ses) could not cross the right common carotid artery.No patient injury was reported.The product was stored and handled according to the instructions for use (ifu).The product was inspected and prepped according to the ifu.There was nothing unusual noted about the stent delivery system prior to use.The device was prepped in the tray.When removed from the tray, the stent was not still constrained within the outer member/sheath.The tuohy borst valve was closed prior to removing the device from the tray.A stopcock was connected to the y-connector of the tuohy borst valve.There was no difficulty encountered flushing the stopcock.There was no difficulty encountered flushing the stent delivery system (sds).The patient had right and left ica stenosis.The intended lesion was not located at the carotid bifurcation.The diameter of the unconstrained stent size was 1-2 mm larger than the vessel diameter.The stent delivery system did not pass through any acute bends.There was difficulty encountered while advancing/tracking the sds towards the lesion.There was unusual force used during the procedure.The lesion was pre-dilated prior to stent implantation.An unknown 4x40 balloon catheter was used to pre-dilate the lesion prior to stent implantation.Nominal pressure was used.The percent stenosis after pre-dilation was 60%.The contrast was mixed with saline and the ratio of the contrast to fluid was 2:1.The user thinks that the event was related to both the stent and procedure.There was difficulty advancing the sds over the guidewire or embolic protection device.The difficulty occurred in the vessel.The procedure completion was delayed.Additional details have been requested but were unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PRECISE PRO RX US CAROTID SYST
Type of Device
STENT, CAROTID
Manufacturer (Section D)
CORDIS CORPORATION
14201 nw 60 avenue
miami lakes FL 33014
Manufacturer (Section G)
CORDIS CORPORATION
14201 nw 60th ave
miami lakes FL 33014
Manufacturer Contact
karla castro
14201 nw 60th ave
miami lakes, FL 33014
7863138372
MDR Report Key8033248
MDR Text Key126657402
Report Number9616099-2018-02488
Device Sequence Number1
Product Code NIM
Combination Product (y/n)N
Reporter Country CodeKS
PMA/PMN Number
P030047
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 11/02/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2019
Device Model NumberPC0840RXC
Device Catalogue NumberPC0840RXC
Device Lot Number17724100
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/17/2018
Initial Date FDA Received11/02/2018
Was Device Evaluated by Manufacturer? No
Date Device Manufactured10/09/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-